Epigenos Biosciences
Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation.
Alert Banner
Alert:NCBiotech's MOVE program wins federal grant to expand biopharma job opportunities for NC’s military community.
Close Search Window
